WHO ICTRP trial
Estudio de los efectos de sildenafilo en combinación con rehabilitación pulmonar…
EUCTR2007-006040-21-ES · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2007-006040-21-ES |
|---|---|
| Public title | Estudio de los efectos de sildenafilo en combinación con rehabilitación pulmonar sobre la tolerancia al esfuerzo en pacientes con enfermedad pulmonar obstructiva crónica e hipertensión pulmonar |
| Scientific title | Estudio de los efectos de sildenafilo en combinación con rehabilitación pulmonar sobre la tolerancia al esfuerzo en pacientes con enfermedad pulmonar obstructiva crónica e hipertensión pulmonar |
| Primary sponsor | Dr. J.A. Barberà. Servicio de Neumología. Hospital Clínic de Barcelona |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Spain |
| Conditions | EPOC e hipertensión pulmonar asociada MedDRA version: 9.1 Level: LLT Classification code 10020787 Term: Hypertension pulmonary MedDRA version: 9.1 Level: LLT Classification code 10010952 Term: COPD |
| Interventions | Trade Name: Revatio Pharmaceutical Form: Tablet Pharmaceutical form of the placebo: Tablet Route of administration of the placebo: Oral use |
| Registration date | Dec 18, 2007 |
| Secondary IDs | SIL-COPD-02 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: